JOBY Flying Taxis Ready To Take Off
JOBY — Playbook & Thesis
Executive Summary
Published: June 22, 2026 | Technical Swing Analysis
PDUFA Catalyst
Joby has completed Stage 4 of the FAA type certification process (testing and analysis), with Stage 5 (show and verify) now underway. Key near-term milestones include ongoing Type Inspection Authorization (TIA) flight testing by FAA pilots expected later in 2026, full type certificate issuance targeted for late 2026, and parallel air carrier certification plus vertiport readiness for initial commercial operations. Dubai launch remains a leading candidate for early 2026 service, supported by ongoing General Civil Aviation Authority coordination. No traditional PDUFA dates apply; instead, these FAA milestones represent the binary regulatory catalysts that could unlock commercial revenue.
Technical Analysis
Live reference: $9.99 session change -0.05% volume 11,196,920
Current price action near $9.80-10.00 shows a reclaim of the psychologically important $10 level on elevated volume (42-45M shares vs. average 29-35M). RSI (14) sits neutral at approximately 43-62, avoiding overbought conditions and allowing room for upside. EMAs present mixed signals with shorter-term lines offering support while longer-term averages (20/50/200-day) act as overhead resistance around 9.7-10.5. Volume profile indicates acceptance near current levels after prior weakness, supporting a cautious bullish bias on any pullback to the recent 9.27 low.
Support & Resistance
Key support sits at the recent intraday low of 9.27 with broader confluence in the 8.00-9.50 zone. Immediate resistance lies at 10.00-10.02 (today's high), followed by higher shelves near 11.00-13.00 aligned with prior highs and EMA clusters. The 52-week range spans 7.75-20.95, providing context for potential extension on certification news.
Pipeline Overview
Joby's primary focus remains its single-platform eVTOL development centered on the S4 aircraft. Manufacturing scale-up in California and Ohio supports fleet expansion, with composites production running at more than 2.5 times prior-year volumes and plans to double capacity in 2027 via a new Dayton, Ohio facility. The company is also advancing operational readiness through the Blade Air Mobility acquisition for passenger services.
Lead Program
The lead program is the Joby S4 eVTOL aircraft, a piloted electric vertical takeoff and landing vehicle designed for urban air taxi operations with a targeted range suitable for short-haul passenger transport. The S4 has achieved extensive flight testing (over 9,000 miles in 2025), first FAA-conforming aircraft flights in Q1 2026, and record progress in Stage 4 certification. This platform underpins all near-term commercialization efforts, including eIPP early operations and Dubai launch plans.
Secondary Program
N/A. Joby operates with a focused single-aircraft platform strategy centered on the S4 eVTOL. Resources are concentrated on certification, manufacturing scale, and initial commercial deployment rather than multiple parallel drug-style development programs typical in biotech.
Market Opportunity
The urban air mobility (UAM) market is projected to grow from approximately USD 6.63 billion in 2026 to over USD 200 billion by 2040, with a CAGR exceeding 27%. Joby targets intra-city passenger transport, with initial fares estimated at $150-300 per trip. Broader advanced air mobility opportunities include cargo and regional routes, supported by government initiatives like the U.S. National Strategy for AAM and eIPP program across multiple states.
Competitive Analysis
Key competitors include Archer Aviation (ACHR) with its Midnight eVTOL and partnerships (United, Southwest), Lilium (LILM) with its jet-powered design focused on longer-range missions, EHang, Volocopter, and legacy players like Airbus and Boeing. Joby differentiates through leading FAA certification progress (Stage 4 complete), extensive real-world flight testing, Blade integration for immediate operations, and strong balance sheet enabling scaled production ahead of peers.
Commercial Readiness
Joby maintains robust commercial readiness with $2.5 billion in cash and short-term investments as of Q1 2026, providing a multi-year runway. Manufacturing is scaling in Marina, California, and Ohio facilities, with propeller blade production underway and capacity expansion plans for 2027. The Blade acquisition adds operational infrastructure and passenger business expertise, positioning the company for initial revenue in 2026.
Bull/Base/Bear Scenarios
Bull
Target: $12.24
Probability: 28%
Breakout + catalyst confirmation; trail toward runner target.
Base
Target: $10.77
Probability: 48%
Mean-reversion / range trade to first resistance; scale out at T1.
Bear
Target: $9.09
Probability: 100% if stop hit
Setup fails — honor stop, no averaging down.
Risk Matrix
- Modest upside at +8.8% from entry.
- AI report flags this as a weak or non-compelling setup.
- Current price action near $9.80-10.00 shows a reclaim of the psychologically important $10 level on elevated volume (42-45M shares vs. average 29-35M). RSI (14) sits neutral at approximately 43-62, avoiding overbought co
Conviction Score
Score: 49/100 (moderate) • Suggested allocation: 1–2%
| Factor | Value | Points |
|---|---|---|
| Target 1 Probability | 52% | 7.8/15 |
| Target 2 Probability | 28% | 2.8/10 |
| Risk / Reward | 1:1.9 | 9/20 |
| Return from Entry | +8.8% | 4/15 |
| Entry Timing | 1.1% from entry | 15/15 |
| Timeframe Fit | 2–4 week swing (10–28 days) | 10/10 |
| Setup Quality | AI report flags weak / non-compelling setup. | 0/15 |
Trade Execution Plan
| Execution Objective | Target Metric | Structural & Statistical Rationale |
|---|---|---|
| Entry Trigger Zone | $9.73 | Stalk confirmation at the planned reload / entry zone before sizing in. |
| Hard Risk Stop Loss | $9.09 | Invalidation below structural support (-6.6% from entry); honor stop — no averaging down. |
| Primary Objective (Target 1) | $10.77 | 48% probability. First scale-out / trim at initial resistance (+10.7% from entry). |
| Secondary Objective (Target 2) | $12.24 | 28% probability. Runner / gap-fill target (+25.8% from entry). |
| Risk / Reward Profile | 1:1.9 | Asymmetric execution framework; peak 1:4.8 to max target. |
| Model Estimated Return | +25.8% | Projected nominal gain from entry trigger to final runner target. |
| Calculated Expected Value | +11.0% | Probability-weighted expectancy factoring paired scale-out and runner hit rates. |
| Capital Allocation Framework | 1–2% | Position size tier from conviction score — scale down when trend or catalyst alignment is mixed. |
Disclaimers
Risk Disclaimer: This analysis is for educational and informational purposes only and does not constitute financial, investment, or trading advice. Trading stocks, especially biotech names, involves substantial risk of loss. Past performance is not indicative of future results. Always conduct your own due diligence and consult a qualified financial advisor.
Comments
Post a Comment